{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:32:55Z","timestamp":1788553975065,"version":"build-2803163510"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Isfahan University of Medical Sciences, Iran, Islamic Republic Of Iran","award":["396765"],"award-info":[{"award-number":["396765"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-024-01619-4","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T07:47:07Z","timestamp":1732693627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Epstein\u2013Barr Virus and gastric carcinoma pathogenesis with emphasis on underlying epigenetic mechanisms"],"prefix":"10.1007","volume":"15","author":[{"given":"Fatemeh","family":"Estaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Zibaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Torabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharareh","family":"Moghim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"issue":"2","key":"1619_CR1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/MOG.0000000000000812","volume":"38","author":"V Kayamba","year":"2022","unstructured":"Kayamba V, Kelly P. Environmental factors associated with gastric carcinogenesis. Curr Opin Gastroenterol. 2022;38(2):156\u201361.","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"1619_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41419-022-04838-1","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Liu F, Yang Y, Yu N, Weng X, Yang Y, et al. Integrated DNA and RNA sequencing reveals early drivers involved in metastasis of gastric cancer. Cell Death Dis. 2022;13(4):392.","journal-title":"Cell Death Dis"},{"key":"1619_CR3","doi-asserted-by":"publisher","first-page":"101404","DOI":"10.1016\/j.eclinm.2022.101404","volume":"47","author":"E Morgan","year":"2022","unstructured":"Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020\u201340: a population-based modelling study. EClinicalMedicine. 2022;47:101404.","journal-title":"EClinicalMedicine"},{"issue":"10125","key":"1619_CR4","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nik\u0161i\u0107 M, et al. Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023\u201375.","journal-title":"Lancet"},{"issue":"3","key":"1619_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3322\/caac.21657","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. Cancer J Clin. 2021;71(3):264\u201379.","journal-title":"Cancer J Clin"},{"issue":"3","key":"1619_CR6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2174\/1573394717666210202103502","volume":"17","author":"M Samare-Najaf","year":"2021","unstructured":"Samare-Najaf M, Samareh A, Jamali N, Abbasi A, Clark CC, Khorchani MJ, Zal F. Adverse effects and safety of Etirinotecan Pegol, a novel topoisomerase inhibitor, in cancer treatment: a systematic review. Curr Cancer Therapy Rev. 2021;17(3):234\u201343.","journal-title":"Curr Cancer Therapy Rev"},{"key":"1619_CR7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.reprotox.2020.07.015","volume":"96","author":"M Samare-Najaf","year":"2020","unstructured":"Samare-Najaf M, Zal F, Safari S. Primary and secondary markers of doxorubicin-induced female infertility and the alleviative properties of quercetin and vitamin E in a rat model. Reprod Toxicol. 2020;96:316\u201326.","journal-title":"Reprod Toxicol"},{"issue":"6","key":"1619_CR8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/jnci\/djx262","volume":"110","author":"WF Anderson","year":"2018","unstructured":"Anderson WF, Rabkin CS, Turner N, Fraumeni JF Jr, Rosenberg PS, Camargo MC. The changing face of noncardia gastric cancer incidence among US non-hispanic whites. J Natl Cancer Inst. 2018;110(6):608\u201315.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"1619_CR9","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","volume":"20","author":"M Arnold","year":"2019","unstructured":"Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TM, Myklebust T\u00c5, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995\u20132014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493\u2013505.","journal-title":"Lancet Oncol"},{"issue":"3","key":"1619_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.giec.2021.03.001","volume":"31","author":"AP Thrift","year":"2021","unstructured":"Thrift AP, Nguyen TH. Gastric cancer epidemiology. Gastrointest Endoscopy Clin. 2021;31(3):425\u201339.","journal-title":"Gastrointest Endoscopy Clin"},{"key":"1619_CR11","doi-asserted-by":"publisher","first-page":"101800","DOI":"10.1016\/j.bpg.2022.101800","volume":"58","author":"F Carneiro","year":"2022","unstructured":"Carneiro F. Familial and hereditary gastric cancer, an overview. Best Pract Res Clin Gastroenterol. 2022;58:101800.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"7","key":"1619_CR12","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.2741\/4059","volume":"17","author":"Q Li","year":"2012","unstructured":"Li Q, Zhang J, Zhou Y, Qiao L. Obesity and gastric cancer. Front Biosci. 2012;17(7):2383\u201390.","journal-title":"Front Biosci"},{"issue":"1","key":"1619_CR13","doi-asserted-by":"publisher","first-page":"11822","DOI":"10.1038\/s41598-021-91275-3","volume":"11","author":"K Papantoniou","year":"2021","unstructured":"Papantoniou K, Casta\u00f1o-Vinyals G, Espinosa A, Turner MC, Mart\u00edn-S\u00e1nchez V, Casabonne D, et al. Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study. Sci Rep. 2021;11(1):11822.","journal-title":"Sci Rep"},{"issue":"7","key":"1619_CR14","doi-asserted-by":"publisher","first-page":"e0265885","DOI":"10.1371\/journal.pone.0265885","volume":"17","author":"MQ Xu","year":"2022","unstructured":"Xu MQ, Sun K, Cao C, Yin HH, Wang XJ, Yin QH, et al. Age-related twin-peak prevalence profiles of H. Pylori infection, gastritis, GIN and gastric cancer: analyses of 70,534 patients with gastroscopic biopsies. PLoS ONE. 2022;17(7):e0265885.","journal-title":"PLoS ONE"},{"issue":"5","key":"1619_CR15","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/annonc\/mdw040","volume":"27","author":"N-Y Chia","year":"2016","unstructured":"Chia N-Y, Tan P. Molecular classification of gastric cancer. Ann Oncol. 2016;27(5):763\u20139.","journal-title":"Ann Oncol"},{"issue":"11","key":"1619_CR16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nrgastro.2014.143","volume":"11","author":"MH McLean","year":"2014","unstructured":"McLean MH, El-Omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol. 2014;11(11):664\u201374.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"1619_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41388-021-02087-8","volume":"41","author":"H-W Huang","year":"2022","unstructured":"Huang H-W, Chen C-Y, Huang Y-H, Yeh C-T, Wang C-S, Chang C-C, Lin K-H. CMAHP promotes metastasis by reducing ubiquitination of snail and inducing angiogenesis via GM-CSF overexpression in gastric cancer. Oncogene. 2022;41(2):159\u201372.","journal-title":"Oncogene"},{"issue":"7","key":"1619_CR18","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3390\/diagnostics12071686","volume":"12","author":"P Ignatavicius","year":"2022","unstructured":"Ignatavicius P, Dauksa A, Zilinskas J, Kazokaite M, Riauka R, Barauskas G. DNA methylation of HOXA11 gene as prognostic molecular marker in human gastric adenocarcinoma. Diagnostics. 2022;12(7):1686.","journal-title":"Diagnostics"},{"issue":"11","key":"1619_CR19","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1038\/sj.bjc.6600319","volume":"86","author":"A Satoh","year":"2002","unstructured":"Satoh A, Toyota M, Itoh F, Kikuchi T, Obata T, Sasaki Y, et al. DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers. Br J Cancer. 2002;86(11):1817\u201323.","journal-title":"Br J Cancer"},{"issue":"5","key":"1619_CR20","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s10565-021-09673-2","volume":"39","author":"S-M Wu","year":"2023","unstructured":"Wu S-M, Jan Y-J, Tsai S-C, Pan H-C, Shen C-C, Yang C-N, et al. Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer. Cell Biol Toxicol. 2023;39(5):1873\u201396.","journal-title":"Cell Biol Toxicol"},{"key":"1619_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12029-020-00518-5","volume":"52","author":"M Alipour","year":"2021","unstructured":"Alipour M. Molecular mechanism of Helicobacter pylori-induced gastric cancer. J Gastrointest Cancer. 2021;52:23\u201330.","journal-title":"J Gastrointest Cancer"},{"issue":"11","key":"1619_CR22","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1002\/ijc.25274","volume":"127","author":"BG Schneider","year":"2010","unstructured":"Schneider BG, Peng DF, Camargo MC, Piazuelo MB, Sicinschi LA, Mera R, et al. Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int J Cancer. 2010;127(11):2588\u201397.","journal-title":"Int J Cancer"},{"key":"1619_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/B978-0-12-819400-3.00025-9","volume-title":"Emerging and reemerging viral pathogens","author":"FE Rihane","year":"2020","unstructured":"Rihane FE, Hassou N, Nadifi S, Ennaji MM. Status of Helicobacter pylori coinfection with Epstein\u2013Barr virus in gastric cancer. In: Ennaji MM, editor. Emerging and reemerging viral pathogens. Amsterdam: Elsevier; 2020. p. 571\u201385."},{"issue":"7","key":"1619_CR24","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/jso.26869","volume":"125","author":"D Shah","year":"2022","unstructured":"Shah D, Bentrem D. Environmental and genetic risk factors for gastric cancer. J Surg Oncol. 2022;125(7):1096\u2013103.","journal-title":"J Surg Oncol"},{"issue":"1","key":"1619_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mib.2007.12.003","volume":"11","author":"M Hatakeyama","year":"2008","unstructured":"Hatakeyama M. SagA of CagA in Helicobacter pylori pathogenesis. Curr Opin Microbiol. 2008;11(1):30\u20137.","journal-title":"Curr Opin Microbiol"},{"key":"1619_CR26","doi-asserted-by":"publisher","first-page":"1105811","DOI":"10.3389\/fcimb.2022.1105811","volume":"12","author":"Y Guo","year":"2023","unstructured":"Guo Y, Cao X-S, Zhou M-G, Yu B. Gastric microbiota in gastric cancer: different roles of Helicobacter pylori and other microbes. Front Cell Infect Microbiol. 2023;12:1105811.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"1619_CR27","first-page":"3456264","volume":"2017","author":"S Singh","year":"2017","unstructured":"Singh S, Jha HC. Status of Epstein\u2013Barr virus coinfection with Helicobacter pylori in gastric cancer. J Oncol. 2017;2017(1):3456264.","journal-title":"J Oncol"},{"issue":"1","key":"1619_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000511243","volume":"102","author":"G Usui","year":"2021","unstructured":"Usui G, Matsusaka K, Mano Y, Urabe M, Funata S, Fukayama M, et al. DNA methylation and genetic aberrations in gastric cancer. Digestion. 2021;102(1):25\u201332.","journal-title":"Digestion"},{"issue":"8","key":"1619_CR29","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1136\/gutjnl-2015-309168","volume":"64","author":"S Mocellin","year":"2015","unstructured":"Mocellin S, Verdi D, Pooley KA, Nitti D. Genetic variation and gastric cancer risk: a field synopsis and meta-analysis. Gut. 2015;64(8):1209\u201319.","journal-title":"Gut"},{"key":"1619_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40880-016-0111-5","volume":"35","author":"T Chen","year":"2016","unstructured":"Chen T, Xu X-Y, Zhou P-H. Emerging molecular classifications and therapeutic implications for gastric cancer. Chin J Cancer. 2016;35:1\u201310.","journal-title":"Chin J Cancer"},{"issue":"3","key":"1619_CR31","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.3892\/mmr.2015.3816","volume":"12","author":"D-G Fu","year":"2015","unstructured":"Fu D-G. Epigenetic alterations in gastric cancer. Mol Med Rep. 2015;12(3):3223\u201330.","journal-title":"Mol Med Rep"},{"issue":"156","key":"1619_CR32","doi-asserted-by":"publisher","first-page":"ra15640","DOI":"10.1126\/scitranslmed.3004504","volume":"4","author":"H Zouridis","year":"2012","unstructured":"Zouridis H, Deng N, Ivanova T, Zhu Y, Wong B, Huang D, et al. Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci Transl Med. 2012;4(156):ra15640\u201340.","journal-title":"Sci Transl Med"},{"issue":"12","key":"1619_CR33","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/ng.982","volume":"43","author":"K Wang","year":"2011","unstructured":"Wang K, Kan J, Yuen ST, Shi ST, Chu KM, Law S, et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet. 2011;43(12):1219\u201323.","journal-title":"Nat Genet"},{"issue":"1","key":"1619_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/1568009617666170203163745","volume":"18","author":"P Hudler","year":"2018","unstructured":"Hudler P. Outlook on epigenetic therapeutic approaches for treatment of gastric cancer. Curr Cancer Drug Targets. 2018;18(1):65\u201388.","journal-title":"Curr Cancer Drug Targets"},{"issue":"14","key":"1619_CR35","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1158\/0008-5472.CAN-11-3919","volume":"72","author":"A Kaneda","year":"2012","unstructured":"Kaneda A, Matsusaka K, Aburatani H, Fukayama M. Epstein\u2013Barr virus infection as an epigenetic driver of tumorigenesis. Cancer Res. 2012;72(14):3445\u201350.","journal-title":"Cancer Res"},{"issue":"8","key":"1619_CR36","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/diagnostics11081375","volume":"11","author":"K Obata","year":"2021","unstructured":"Obata K, Okui T, Ono S, Umemori K, Ryumon S, Ono K, et al. Comparative study on Epstein\u2013Barr virus-positive mucocutaneous ulcer and methotrexate-associated lymphoproliferative disorders developed in the oral mucosa: a case series of 10 patients and literature review. Diagnostics. 2021;11(8):1375.","journal-title":"Diagnostics"},{"key":"1619_CR37","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/978-3-030-54441-6_179","volume-title":"Family Medicine: principles and practice","author":"S Mullick","year":"2022","unstructured":"Mullick S. Epstein\u2013Barr Virus infection and infectious mononucleosis. In: Paulman P, Taylor R, Paulman A, Nasir L, editor. Family Medicine: principles and practice. Berlin: Springer; 2022. pp. 521\u20135."},{"issue":"4","key":"1619_CR38","doi-asserted-by":"publisher","first-page":"e1010400","DOI":"10.1371\/journal.ppat.1010400","volume":"18","author":"LB Caruso","year":"2022","unstructured":"Caruso LB, Guo R, Keith K, Madzo J, Maestri D, Boyle S, et al. The nuclear lamina binds the EBV genome during latency and regulates viral gene expression. PLoS Pathog. 2022;18(4):e1010400.","journal-title":"PLoS Pathog"},{"issue":"7","key":"1619_CR39","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/NEN.0b013e3181e332ec","volume":"69","author":"B Serafini","year":"2010","unstructured":"Serafini B, Severa M, Columba-Cabezas S, Rosicarelli B, Veroni C, Chiappetta G, et al. Epstein\u2013Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J Neuropathol Exp Neurol. 2010;69(7):677\u201393.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1619_CR40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fimmu.2018.00198","volume":"9","author":"S Arjunaraja","year":"2018","unstructured":"Arjunaraja S, Angelus P, Su HC, Snow AL. Impaired control of epstein\u2013barr virus infection in B-cell expansion with NF-\u03baB and T-cell anergy disease. Front Immunol. 2018;9:198.","journal-title":"Front Immunol"},{"issue":"3","key":"1619_CR41","doi-asserted-by":"publisher","first-page":"e00836","DOI":"10.1128\/mbio.00836-22","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Ungerleider N, Hoffman BA, Kara M, Farrell PJ, Flemington EK, et al. A polymorphism in the Epstein\u2013Barr virus EBER2 noncoding RNA drives in vivo expansion of latently infected B cells. Mbio. 2022;13(3):e00836\u201322.","journal-title":"Mbio"},{"key":"1619_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-9378-9-38","volume":"9","author":"G Khan","year":"2014","unstructured":"Khan G, Hashim MJ. Global burden of deaths from Epstein\u2013Barr virus attributable malignancies 1990\u20132010. Infect Agents Cancer. 2014;9:1\u201311.","journal-title":"Infect Agents Cancer"},{"issue":"12","key":"1619_CR43","first-page":"609","volume":"33","author":"M Rowe","year":"2014","unstructured":"Rowe M, Fitzsimmons L, Bell AI. Epstein\u2013Barr virus and Burkitt lymphoma. Chin J Cancer. 2014;33(12):609.","journal-title":"Chin J Cancer"},{"key":"1619_CR44","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3389\/fonc.2019.00713","volume":"9","author":"C Shannon-Lowe","year":"2019","unstructured":"Shannon-Lowe C, Rickinson A. The global landscape of EBV-associated tumors. Front Oncol. 2019;9:713.","journal-title":"Front Oncol"},{"issue":"1","key":"1619_CR45","doi-asserted-by":"publisher","first-page":"e1008223","DOI":"10.1371\/journal.ppat.1008223","volume":"16","author":"S Zhu","year":"2020","unstructured":"Zhu S, Chen J, Xiong Y, Kamara S, Gu M, Tang W, et al. Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma. PLoS Pathog. 2020;16(1):e1008223.","journal-title":"PLoS Pathog"},{"issue":"8\u20139","key":"1619_CR46","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.micinf.2011.04.002","volume":"13","author":"B Luo","year":"2011","unstructured":"Luo B, Tang X, Jia Y, Wang Y, Chao Y, Zhao C. Sequence variation of Epstein\u2013Barr virus (EBV) BZLF1 gene in EBV-associated gastric carcinomas and nasopharyngeal carcinomas in Northern China. Microbes Infect. 2011;13(8\u20139):776\u201382.","journal-title":"Microbes Infect"},{"issue":"11","key":"1619_CR47","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2217\/fvl-2018-0071","volume":"13","author":"LJ Stanland","year":"2018","unstructured":"Stanland LJ, Luftig MA. Molecular features and translational outlook for Epstein\u2013Barr virus-associated gastric cancer. Future Virol. 2018;13(11):803\u201318.","journal-title":"Future Virol"},{"issue":"4","key":"1619_CR48","doi-asserted-by":"publisher","first-page":"01006","DOI":"10.1128\/mbio","volume":"10","author":"JE Messinger","year":"2019","unstructured":"Messinger JE, Dai J, Stanland LJ, Price AM, Luftig MA. Identification of host biomarkers of Epstein\u2013Barr virus latency IIb and latency III. MBio. 2019;10(4):01006\u201319. https:\/\/doi.org\/10.1128\/mbio.","journal-title":"MBio"},{"key":"1619_CR49","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/B978-0-12-800098-4.00006-4","volume":"88","author":"AM Price","year":"2014","unstructured":"Price AM, Luftig MA. Dynamic Epstein\u2013Barr virus gene expression on the path to B-cell transformation. Adv Virus Res. 2014;88:279\u2013313.","journal-title":"Adv Virus Res"},{"key":"1619_CR50","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.canlet.2020.11.019","volume":"499","author":"BFR Caetano","year":"2021","unstructured":"Caetano BFR, Jorge BAS, M\u00fcller-Coan BG, de Oliveira DE. Epstein\u2013Barr virus microRNAs in the pathogenesis of human cancers. Cancer Lett. 2021;499:14\u201323.","journal-title":"Cancer Lett"},{"issue":"4","key":"1619_CR51","doi-asserted-by":"publisher","first-page":"e01495","DOI":"10.1128\/jvi.01495-21","volume":"96","author":"DN Fachko","year":"2022","unstructured":"Fachko DN, Chen Y, Skalsky RL. Epstein\u2013Barr Virus miR-BHRF1-3 targets the BZLF1 3\u2019UTR and regulates the lytic cycle. J Virol. 2022;96(4):e01495-21.","journal-title":"J Virol"},{"issue":"3","key":"1619_CR52","first-page":"377","volume":"3","author":"A Burke","year":"1990","unstructured":"Burke A, Yen T, Shekitka K, Sobin L. Lymphoepithelial carcinoma of the stomach with Epstein\u2013Barr virus demonstrated by polymerase chain reaction. Mod Pathol. 1990;3(3):377\u201380.","journal-title":"Mod Pathol"},{"issue":"8","key":"1619_CR53","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1111\/cas.14978","volume":"112","author":"W Li","year":"2021","unstructured":"Li W, Okabe A, Usui G, Fukuyo M, Matsusaka K, Rahmutulla B, et al. Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein\u2013Barr virus\u2013positive gastric cancer. Cancer Sci. 2021;112(8):3349\u201362.","journal-title":"Cancer Sci"},{"key":"1619_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00432-021-03824-y","volume":"148","author":"Y Wong","year":"2022","unstructured":"Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ. Estimating the global burden of Epstein\u2013Barr virus-related cancers. J Cancer Res Clin Oncol. 2022;148:1\u201316.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"1619_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-020-00376-4","volume":"6","author":"Y Cao","year":"2021","unstructured":"Cao Y, Xie L, Shi F, Tang M, Li Y, Hu J, et al. Targeting the signaling in Epstein\u2013Barr virus-associated diseases: mechanism, regulation, and clinical study. Signal Transduct Target Therapy. 2021;6(1):15.","journal-title":"Signal Transduct Target Therapy"},{"issue":"15","key":"1619_CR56","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.3390\/cancers13153909","volume":"13","author":"KI Notarte","year":"2021","unstructured":"Notarte KI, Senanayake S, Macaranas I, Albano PM, Mundo L, Fennell E, et al. MicroRNA and other non-coding RNAs in Epstein\u2013Barr virus-associated cancers. Cancers. 2021;13(15):3909.","journal-title":"Cancers"},{"issue":"7","key":"1619_CR57","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.dld.2021.06.004","volume":"54","author":"H Song","year":"2022","unstructured":"Song H, Zhang Y, Liu J, Liu W, Luo B. Activation of DNA methyltransferase 3a by Epstein\u2013Barr nuclear antigen 1 in gastric carcinoma. Dig Liver Dis. 2022;54(7):973\u201383.","journal-title":"Dig Liver Dis"},{"issue":"5","key":"1619_CR58","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1111\/cas.14370","volume":"111","author":"Y Asakawa","year":"2020","unstructured":"Asakawa Y, Okabe A, Fukuyo M, Li W, Ikeda E, Mano Y, et al. Epstein\u2013Barr virus\u2010positive gastric cancer involves enhancer activation through activating transcription factor 3. Cancer Sci. 2020;111(5):1818\u201328.","journal-title":"Cancer Sci"},{"issue":"9","key":"1619_CR59","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41588-020-0665-7","volume":"52","author":"A Okabe","year":"2020","unstructured":"Okabe A, Huang KK, Matsusaka K, Fukuyo M, Xing M, Ong X, et al. Cross-species chromatin interactions drive transcriptional rewiring in Epstein\u2013Barr virus\u2013positive gastric adenocarcinoma. Nat Genet. 2020;52(9):919\u201330.","journal-title":"Nat Genet"},{"key":"1619_CR60","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.virol.2021.07.009","volume":"562","author":"K Shire","year":"2021","unstructured":"Shire K, Marcon E, Greenblatt J, Frappier L. Characterization of a cancer-associated Epstein\u2013Barr virus EBNA1 variant reveals a novel interaction with PLOD1 and PLOD3. Virology. 2021;562:103\u20139.","journal-title":"Virology"},{"issue":"2","key":"1619_CR61","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/microorganisms8020258","volume":"8","author":"JH Yoon","year":"2020","unstructured":"Yoon JH, Min K, Lee SK. Epstein\u2013Barr virus miR-BART17-5p promotes migration and Anchorage-independent growth by targeting kruppel-like factor 2 in gastric cancer. Microorganisms. 2020;8(2):258.","journal-title":"Microorganisms"},{"issue":"4","key":"1619_CR62","doi-asserted-by":"publisher","first-page":"166049","DOI":"10.1016\/j.bbadis.2020.166049","volume":"1867","author":"K Torres","year":"2021","unstructured":"Torres K, Landeros N, Wichmann IA, Polakovicova I, Aguayo F, Corvalan AH. EBV miR-BARTs and human lncRNAs: shifting the balance in competing endogenous RNA networks in EBV-associated gastric cancer. Biochim Biophys Acta Mol Basis Dis. 2021;1867(4):166049.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"9","key":"1619_CR63","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1002\/jcp.30297","volume":"236","author":"A Zebardast","year":"2021","unstructured":"Zebardast A, Tehrani SS, Latifi T, Sadeghi F. Critical review of Epstein\u2013Barr virus microRNAs relation with EBV-associated gastric cancer. J Cell Physiol. 2021;236(9):6136\u201353.","journal-title":"J Cell Physiol"},{"issue":"6","key":"1619_CR64","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11262-022-01925-5","volume":"58","author":"W Liu","year":"2022","unstructured":"Liu W, Xiao H, Song H, An S, Luo B. Transcriptome sequencing of LMP2A-transfected gastric cancer cells identifies potential biomarkers in EBV-associated gastric cancer. Virus Genes. 2022;58(6):515\u201326.","journal-title":"Virus Genes"},{"issue":"11","key":"1619_CR65","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.3390\/ijms21114012","volume":"21","author":"J Machlowska","year":"2020","unstructured":"Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21(11):4012.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1619_CR66","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3390\/jcm9051427","volume":"9","author":"MG Rodriquenz","year":"2020","unstructured":"Rodriquenz MG, Roviello G, D\u2019Angelo A, Lavacchi D, Roviello F, Polom K. MSI and EBV positive gastric cancer\u2019s subgroups and their link with novel immunotherapy. J Clin Med. 2020;9(5):1427.","journal-title":"J Clin Med"},{"issue":"5","key":"1619_CR67","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s10120-021-01215-3","volume":"24","author":"M Saito","year":"2021","unstructured":"Saito M, Kono K. Landscape of EBV-positive gastric cancer. Gastric Cancer. 2021;24(5):983\u20139.","journal-title":"Gastric Cancer"},{"issue":"3","key":"1619_CR68","first-page":"2125","volume":"19","author":"H Zhou","year":"2019","unstructured":"Zhou H, Tan S, Li H, Lin X. Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma. Mol Med Rep. 2019;19(3):2125\u201336.","journal-title":"Mol Med Rep"},{"key":"1619_CR69","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.omtn.2021.03.023","volume":"24","author":"Q Meng","year":"2021","unstructured":"Meng Q, Lu Y-X, Ruan D-Y, Yu K, Chen Y-X, Xiao M, et al. DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in gastric cancer. Mol Therapy Nucl Acids. 2021;24:695\u2013710.","journal-title":"Mol Therapy Nucl Acids"},{"issue":"11","key":"1619_CR70","first-page":"52","volume":"10","author":"A AR","year":"2019","unstructured":"AR A, Rajashekar M. Comparison between conventional gastric adenocarcinoma and EBV assocated gastric carcinoma. Indian J Public Health Res Dev. 2019;10(11):52\u201361.","journal-title":"Indian J Public Health Res Dev"},{"issue":"3","key":"1619_CR71","first-page":"256","volume":"88","author":"A Vidal-Realpe","year":"2023","unstructured":"Vidal-Realpe A, Due\u00f1as-Cuellar R, Ni\u00f1o-Casta\u00f1o V, Mora-Obando D, Arias-Agudelo J, Bola\u00f1os H. Clinical and pathologic characteristics of gastric adenocarcinoma associated with Epstein\u2013Barr virus in a region with a high incidence of gastric cancer in Colombia. Rev Gastroenterol M\u00e9x. 2023;88(3):256\u201366.","journal-title":"Rev Gastroenterol M\u00e9x"},{"issue":"6280","key":"1619_CR72","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1126\/science.aad9024","volume":"351","author":"D Hnisz","year":"2016","unstructured":"Hnisz D, Weintraub AS, Day DS, Valton A-L, Bak RO, Li CH, et al. Activation of proto-oncogenes by disruption of chromosome neighborhoods. Science. 2016;351(6280):1454\u20138.","journal-title":"Science"},{"issue":"1","key":"1619_CR73","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41392-021-00771-5","volume":"7","author":"B Huang","year":"2022","unstructured":"Huang B, Li Q, Geng Q, Lao J, Guo J, Huang S, Xu D. ASTE1 frameshift mutation triggers the immune response in Epstein\u2013Barr virus-associated gastric cancer. Signal Transduct Target Therapy. 2022;7(1):4.","journal-title":"Signal Transduct Target Therapy"},{"issue":"6","key":"1619_CR74","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1053\/j.gastro.2014.08.036","volume":"147","author":"Q Liang","year":"2014","unstructured":"Liang Q, Yao X, Tang S, Zhang J, Yau TO, Li X, et al. Integrative identification of Epstein\u2013Barr virus\u2013associated mutations and epigenetic alterations in gastric cancer. Gastroenterology. 2014;147(6):1350\u201362. e4.","journal-title":"Gastroenterology"},{"issue":"2","key":"1619_CR75","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/cncr.27724","volume":"119","author":"J Zhao","year":"2013","unstructured":"Zhao J, Liang Q, Cheung KF, Kang W, Lung RW, Tong JH, et al. Genome-wide identification of Epstein\u2010Barr virus\u2013driven promoter methylation profiles of human genes in gastric cancer cells. Cancer. 2013;119(2):304\u201312.","journal-title":"Cancer"},{"key":"1619_CR76","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s13402-020-00542-4","volume":"43","author":"J Wei","year":"2020","unstructured":"Wei J, Guo C, An X, Miao W, Zhang C, Wang B, et al. Tumor cell-expressed IL-15R\u03b1 drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer. Cell Oncol. 2020;43:1085\u201397.","journal-title":"Cell Oncol"},{"issue":"1","key":"1619_CR77","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1053\/j.gastro.2014.09.020","volume":"148","author":"SY Kim","year":"2015","unstructured":"Kim SY, Park C, Kim H-J, Park J, Hwang J, Kim J-I, et al. Deregulation of immune response genes in patients with Epstein\u2013Barr virus-associated gastric cancer and outcomes. Gastroenterology. 2015;148(1):137\u201347. e9.","journal-title":"Gastroenterology"},{"issue":"8","key":"1619_CR78","doi-asserted-by":"publisher","first-page":"e1008778","DOI":"10.1371\/journal.ppat.1008778","volume":"16","author":"GN Fiches","year":"2020","unstructured":"Fiches GN, Zhou D, Kong W, Biswas A, Ahmed EH, Baiocchi RA, et al. Profiling of immune related genes silenced in EBV-positive gastric carcinoma identified novel restriction factors of human gammaherpesviruses. PLoS Pathog. 2020;16(8):e1008778.","journal-title":"PLoS Pathog"},{"key":"1619_CR79","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s12275-014-4654-3","volume":"53","author":"SM Dong","year":"2015","unstructured":"Dong SM, Lee HG, Cho S-G, Kwon S-H, Yoon H, Kwon H-J, et al. Hypermethylation of the interferon regulatory factor 5 promoter in Epstein\u2013Barr virus-associated gastric carcinoma. J Microbiol. 2015;53:70\u20136.","journal-title":"J Microbiol"},{"key":"1619_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-019-0747-5","volume":"11","author":"W-L Fang","year":"2019","unstructured":"Fang W-L, Chen M-H, Huang K-H, Chang S-C, Lin C-H, Chao Y, et al. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array. Clin Epigenetics. 2019;11:1\u201316.","journal-title":"Clin Epigenetics"},{"issue":"1","key":"1619_CR81","doi-asserted-by":"publisher","first-page":"7924","DOI":"10.1038\/s41598-017-08370-7","volume":"7","author":"A Okabe","year":"2017","unstructured":"Okabe A, Funata S, Matsusaka K, Namba H, Fukuyo M, Rahmutulla B, et al. Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein\u2013Barr virus. Sci Rep. 2017;7(1):7924.","journal-title":"Sci Rep"},{"issue":"4","key":"1619_CR82","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1002\/jcp.27220","volume":"234","author":"E Ghadami","year":"2019","unstructured":"Ghadami E, Nikbakhsh N, Fattahi S, Kosari-Monfared M, Ranaee M, Taheri H, et al. Epigenetic alterations of CYLD promoter modulate its expression in gastric adenocarcinoma: a footprint of infections. J Cell Physiol. 2019;234(4):4115\u201324.","journal-title":"J Cell Physiol"},{"key":"1619_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-015-0525-y","volume":"32","author":"D He","year":"2015","unstructured":"He D, Zhang Y-w, Zhang N-n, Zhou L, Chen J-n, Jiang Y, Shao C-k. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein\u2013Barr virus-associated gastric carcinomas. Med Oncol. 2015;32:1\u201316.","journal-title":"Med Oncol"},{"issue":"6","key":"1619_CR84","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.dld.2016.02.017","volume":"48","author":"J Li","year":"2016","unstructured":"Li J, Liu X, Liu M, Che K, Luo B. Methylation and expression of Epstein\u2013Barr virus latent membrane protein 1, 2A and 2B in EBV-associated gastric carcinomas and cell lines. Dig Liver Dis. 2016;48(6):673\u201380.","journal-title":"Dig Liver Dis"},{"key":"1619_CR85","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00705-012-1481-x","volume":"158","author":"X Liu","year":"2013","unstructured":"Liu X, Wang Y, Wang X, Sun Z, Li L, Tao Q, Luo B. Epigenetic silencing of WNT5A in Epstein\u2013Barr virus-associated gastric carcinoma. Arch Virol. 2013;158:123\u201332.","journal-title":"Arch Virol"},{"issue":"2","key":"1619_CR86","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/onc.2016.187","volume":"36","author":"J Yu","year":"2017","unstructured":"Yu J, Liang Q, Wang J, Wang K, Gao J, Zhang J, et al. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype. Oncogene. 2017;36(2):182\u201393.","journal-title":"Oncogene"},{"issue":"12","key":"1619_CR87","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1038\/bjc.2013.263","volume":"108","author":"J Zhao","year":"2013","unstructured":"Zhao J, Liang Q, Cheung K, Kang W, Dong Y, Lung RW, et al. Somatostatin receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer. Br J Cancer. 2013;108(12):2557\u201364.","journal-title":"Br J Cancer"},{"issue":"33","key":"1619_CR88","doi-asserted-by":"publisher","first-page":"55265","DOI":"10.18632\/oncotarget.19423","volume":"8","author":"S Funata","year":"2017","unstructured":"Funata S, Matsusaka K, Yamanaka R, Yamamoto S, Okabe A, Fukuyo M, et al. Histone modification alteration coordinated with acquisition of promoter DNA methylation during Epstein\u2013Barr virus infection. Oncotarget. 2017;8(33):55265.","journal-title":"Oncotarget"},{"issue":"1","key":"1619_CR89","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/carcin\/bgaa123","volume":"42","author":"K Kase","year":"2021","unstructured":"Kase K, Saito M, Nakajima S, Takayanagi D, Saito K, Yamada L, et al. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation. Carcinogenesis. 2021;42(1):21\u201330.","journal-title":"Carcinogenesis"},{"issue":"10","key":"1619_CR90","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/jmv.24863","volume":"89","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Liu W, Liu J, Wang J, Luo B. The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer. J Med Virol. 2017;89(10):1844\u201351.","journal-title":"J Med Virol"},{"issue":"1","key":"1619_CR91","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/jgh.13432","volume":"32","author":"CY Tsai","year":"2017","unstructured":"Tsai CY, Liu YY, Liu KH, Hsu JT, Chen TC, Chiu CT, Yeh TS. Comprehensive profiling of virus microRNAs of Epstein\u2013Barr virus-associated gastric carcinoma: highlighting the interactions of ebv\u2010Bart9 and host tumor cells. J Gastroenterol Hepatol. 2017;32(1):82\u201391.","journal-title":"J Gastroenterol Hepatol"},{"key":"1619_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-020-00989-0","volume":"13","author":"M Zhu","year":"2021","unstructured":"Zhu M, Liang Q, Chen T, Kong Q, Ye G, Yu S, et al. Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer. Clin Epigenetics. 2021;13:1\u201318.","journal-title":"Clin Epigenetics"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01619-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-024-01619-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01619-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T09:10:54Z","timestamp":1732698654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-024-01619-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1619"],"URL":"https:\/\/doi.org\/10.1007\/s12672-024-01619-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"assertion":[{"value":"2 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"719"}}